MVC 9 PLUS 3 INJ
MVC 9 PLUS 3 INJ
Discontinued
DIN Number
01945637
Drug Class
Human
Market Date
Dec 31, 1984
Company
HC
lyphomed, division of fujisawa canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01945637
AIG Number1216318001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XC VITAMINS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification88:28.00
Health Canada Classification
ACTIVE INGREDIENTS (12)
ASCORBIC ACIDActive
Strength: 100 MG / 5 ML
Monograph: ASCORBIC ACID
BIOTINActive
Strength: 60 MCG / 5 ML
Monograph: BIOTIN
DEXPANTHENOLActive
Strength: 15 MG / 5 ML
Monograph: DEXPANTHENOL
DL-ALPHA TOCOPHERYL ACETATEActive
Strength: 10 UNIT / 5 ML
Monograph: DL-ALPHA TOCOPHERYL ACETATE
FOLIC ACIDActive
Strength: .4 MG / 5 ML
Monograph: FOLIC ACID
NICOTINAMIDEActive
Strength: 40 MG / 5 ML
Monograph: NICOTINAMIDE
PYRIDOXINE HYDROCHLORIDEActive
Strength: 4 MG / 5 ML
Monograph: PYRIDOXINE HYDROCHLORIDE
RIBOFLAVIN 5'-PHOSPHATE SODIUMActive
Strength: 3.6 MG / 5 ML
Monograph: RIBOFLAVIN 5'-PHOSPHATE SODIUM
THIAMINE HYDROCHLORIDEActive
Strength: 3 MG / 5 ML
Monograph: THIAMINE HYDROCHLORIDE
VITAMIN AActive
Strength: 3300 UNIT / 5 ML
Monograph: VITAMIN A
VITAMIN B12Active
Strength: 5 MCG / 5 ML
Monograph: VITAMIN B12
VITAMIN D2Active
Strength: 200 UNIT / 5 ML
Monograph: VITAMIN D2